-
1
-
-
33744948333
-
Testosterone therapy in adult men with androgen deficiency syndromes: An endocrine society clinical practice guideline
-
Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in adult men with androgen deficiency syndromes: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006;91:1995-2010.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 1995-2010
-
-
Bhasin, S.1
Cunningham, G.R.2
Hayes, F.J.3
Matsumoto, A.M.4
Snyder, P.J.5
Swerdloff, R.S.6
Montori, V.M.7
-
2
-
-
77954414397
-
Identification of late-onset hypogonadism in middle-aged and elderly men
-
Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva FF, Forti G, Giwercman A, Han TS, Kula K, Lean ME, Pendleton N, Punab M, Boonen S, Vanderschueren D, Labrie F, Huhtaniemi IT; EMAS Group. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010;363:123-135.
-
(2010)
N Engl J Med
, vol.363
, pp. 123-135
-
-
Wu, F.C.1
Tajar, A.2
Beynon, J.M.3
Pye, S.R.4
Silman, A.J.5
Finn, J.D.6
O'Neill, T.W.7
Bartfai, G.8
Casanueva, F.F.9
Forti, G.10
Giwercman, A.11
Han, T.S.12
Kula, K.13
Lean, M.E.14
Pendleton, N.15
Punab, M.16
Boonen, S.17
Vanderschueren, D.18
Labrie, F.19
Huhtaniemi, I.T.20
more..
-
4
-
-
84873060198
-
The 20-year public health impact and direct cost of testosterone deficiency in U.S. men
-
Moskovic DJ, Araujo AB, Lipshultz LI, Khera M. The 20-year public health impact and direct cost of testosterone deficiency in U.S. men. J Sex Med 2013;10:562-569.
-
(2013)
J Sex Med
, vol.10
, pp. 562-569
-
-
Moskovic, D.J.1
Araujo, A.B.2
Lipshultz, L.I.3
Khera, M.4
-
5
-
-
84872852291
-
Testosterone deficiency in men: Systematic review and standard operating procedures for diagnosis and treatment
-
Buvat J, Maggi M, Guay A, Torres LO. Testosterone deficiency in men: Systematic review and standard operating procedures for diagnosis and treatment. J Sex Med 2013;10:245-284.
-
(2013)
J Sex Med
, vol.10
, pp. 245-284
-
-
Buvat, J.1
Maggi, M.2
Guay, A.3
Torres, L.O.4
-
6
-
-
33745108447
-
Prevalence of hypogonadism in males aged at least 45 years: The HIM study
-
Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: The HIM study. Int J Clin Pract 2006;60:762-769.
-
(2006)
Int J Clin Pract
, vol.60
, pp. 762-769
-
-
Mulligan, T.1
Frick, M.F.2
Zuraw, Q.C.3
Stemhagen, A.4
McWhirter, C.5
-
7
-
-
68149178808
-
Welcoming low testosterone as a cardiovascular risk factor
-
Maggio M, Basaria S. Welcoming low testosterone as a cardiovascular risk factor. Int J Impot Res 2009;21:261-264.
-
(2009)
Int J Impot Res
, vol.21
, pp. 261-264
-
-
Maggio, M.1
Basaria, S.2
-
8
-
-
84866166373
-
Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?
-
Giannoulis MG, Martin FC, Nair KS, Umpleby AM, Sonksen P. Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? Endocr Rev 2012;33:314-377.
-
(2012)
Endocr Rev
, vol.33
, pp. 314-377
-
-
Giannoulis, M.G.1
Martin, F.C.2
Nair, K.S.3
Umpleby, A.M.4
Sonksen, P.5
-
9
-
-
26444515048
-
The decline of androgen levels in elderly men and its clinical and therapeutic implications
-
Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005;26:833-876.
-
(2005)
Endocr Rev
, vol.26
, pp. 833-876
-
-
Kaufman, J.M.1
Vermeulen, A.2
-
10
-
-
33751533215
-
Association of specific symptoms and metabolic risks with serum testosterone in older men
-
Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006;91:4335-4343.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 4335-4343
-
-
Zitzmann, M.1
Faber, S.2
Nieschlag, E.3
-
11
-
-
33644828241
-
Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men
-
Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 2006;91:843-850.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 843-850
-
-
Kupelian, V.1
Page, S.T.2
Araujo, A.B.3
Travison, T.G.4
Bremner, W.J.5
McKinlay, J.B.6
-
12
-
-
43949086558
-
Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: The Tromso study
-
Agledahl I, Skjaerpe PA, Hansen JB, Svartberg J. Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: The Tromso study. Nutr Metab Cardiovasc Dis 2008;18:256-262.
-
(2008)
Nutr Metab Cardiovasc Dis
, vol.18
, pp. 256-262
-
-
Agledahl, I.1
Skjaerpe, P.A.2
Hansen, J.B.3
Svartberg, J.4
-
13
-
-
0036342660
-
Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: The Rotterdam study
-
Hak AE, Witteman JC, de Jong FH, Geerlings MI, Hofman A, Pols HA. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: The Rotterdam study. J Clin Endocrinol Metab 2002;87:3632-3639.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 3632-3639
-
-
Hak, A.E.1
Witteman, J.C.2
de Jong, F.H.3
Geerlings, M.I.4
Hofman, A.5
Pols, H.A.6
-
15
-
-
84869003664
-
Testosterone and cardiovascular risk in patients with erectile dysfunction
-
Corona G, Rastrelli G, Balercia G, Sforza A, Forti G, Maggi M. Testosterone and cardiovascular risk in patients with erectile dysfunction. J Endocrinol Invest 2012;35:809-816.
-
(2012)
J Endocrinol Invest
, vol.35
, pp. 809-816
-
-
Corona, G.1
Rastrelli, G.2
Balercia, G.3
Sforza, A.4
Forti, G.5
Maggi, M.6
-
16
-
-
79952541665
-
Testosterone, cardiovascular disease and the metabolic syndrome
-
Corona G, Rastrelli G, Vignozzi L, Mannucci E, Maggi M. Testosterone, cardiovascular disease and the metabolic syndrome. Best Pract Res Clin Endocrinol Metab 2011;25:337-353.
-
(2011)
Best Pract Res Clin Endocrinol Metab
, vol.25
, pp. 337-353
-
-
Corona, G.1
Rastrelli, G.2
Vignozzi, L.3
Mannucci, E.4
Maggi, M.5
-
17
-
-
80054089894
-
Hypogonadism and metabolic syndrome
-
Corona G, Rastrelli G, Morelli A, Vignozzi L, Mannucci E, Maggi M. Hypogonadism and metabolic syndrome. J Endocrinol Invest 2011;34:557-567.
-
(2011)
J Endocrinol Invest
, vol.34
, pp. 557-567
-
-
Corona, G.1
Rastrelli, G.2
Morelli, A.3
Vignozzi, L.4
Mannucci, E.5
Maggi, M.6
-
18
-
-
74049143811
-
Symptomatic response rates to testosterone therapy and the likelihood of completing 12 months of therapy in clinical practice
-
Rhoden EL, Morgentaler A. Symptomatic response rates to testosterone therapy and the likelihood of completing 12 months of therapy in clinical practice. J Sex Med 2010;7:277-283.
-
(2010)
J Sex Med
, vol.7
, pp. 277-283
-
-
Rhoden, E.L.1
Morgentaler, A.2
-
19
-
-
0036220738
-
Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: A phase II study
-
von Eckardstein S, Nieschlag E. Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: A phase II study. J Androl 2002;23:419-425.
-
(2002)
J Androl
, vol.23
, pp. 419-425
-
-
von Eckardstein, S.1
Nieschlag, E.2
-
20
-
-
84856530228
-
A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel®) insertion
-
McCullough AR, Khera M, Goldstein I, Hellstrom WJ, Morgentaler A, Levine LA. A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel®) insertion. J Sex Med 2012;9:594-601.
-
(2012)
J Sex Med
, vol.9
, pp. 594-601
-
-
McCullough, A.R.1
Khera, M.2
Goldstein, I.3
Hellstrom, W.J.4
Morgentaler, A.5
Levine, L.A.6
-
21
-
-
84874409333
-
Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets
-
Pastuszak AW, Mittakanti H, Liu JS, Gomez L, Lipshultz LI, Khera M. Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets. J Androl 2012;33:927-937.
-
(2012)
J Androl
, vol.33
, pp. 927-937
-
-
Pastuszak, A.W.1
Mittakanti, H.2
Liu, J.S.3
Gomez, L.4
Lipshultz, L.I.5
Khera, M.6
-
22
-
-
0038410330
-
Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGel
-
Marbury T, Hamill E, Bachand R, Sebree T, Smith T. Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGel. Biopharm Drug Dispos 2003;24:115-120.
-
(2003)
Biopharm Drug Dispos
, vol.24
, pp. 115-120
-
-
Marbury, T.1
Hamill, E.2
Bachand, R.3
Sebree, T.4
Smith, T.5
-
23
-
-
40649125607
-
Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men
-
Grober ED, Khera M, Soni SD, Espinoza MG, Lipshultz LI. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men. Int J Impot Res 2008;20:213-217.
-
(2008)
Int J Impot Res
, vol.20
, pp. 213-217
-
-
Grober, E.D.1
Khera, M.2
Soni, S.D.3
Espinoza, M.G.4
Lipshultz, L.I.5
-
24
-
-
0023194264
-
Hormone kinetics after intramuscular testosterone cypionate
-
Nankin HR. Hormone kinetics after intramuscular testosterone cypionate. Fertil Steril 1987;47:1004-1009.
-
(1987)
Fertil Steril
, vol.47
, pp. 1004-1009
-
-
Nankin, H.R.1
-
25
-
-
84883559843
-
Factors influencing patient decisions to initiate and discontinue subcutaneous testosterone pellets (Testopel®) for treatment of hypogonadism
-
Smith RP, Khanna A, Coward RM, Rajanahally S, Kovac JR, Gonzales MA, Lipshultz LI. Factors influencing patient decisions to initiate and discontinue subcutaneous testosterone pellets (Testopel®) for treatment of hypogonadism. J Sex Med 2013;10:2326-2333.
-
(2013)
J Sex Med
, vol.10
, pp. 2326-2333
-
-
Smith, R.P.1
Khanna, A.2
Coward, R.M.3
Rajanahally, S.4
Kovac, J.R.5
Gonzales, M.A.6
Lipshultz, L.I.7
-
26
-
-
84875443438
-
The evidence for seasonal variations of testosterone in men
-
Smith RP, Coward RM, Kovac JR, Lipshultz LI. The evidence for seasonal variations of testosterone in men. Maturitas 2013;pii: S0378-5122(12)00403-3. doi: 10.1016/j.maturitas.2012.12.003.
-
(2013)
Maturitas
-
-
Smith, R.P.1
Coward, R.M.2
Kovac, J.R.3
Lipshultz, L.I.4
-
27
-
-
17744390362
-
Effects of testosterone replacement in hypogonadal men
-
Snyder PJ, Peachey H, Berlin JA, Hannoush P, Haddad G, Dlewati A, Santanna J, Loh L, Lenrow DA, Holmes JH, Kapoor SC, Atkinson LE, Strom BL. Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 2000;85:2670-2677.
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 2670-2677
-
-
Snyder, P.J.1
Peachey, H.2
Berlin, J.A.3
Hannoush, P.4
Haddad, G.5
Dlewati, A.6
Santanna, J.7
Loh, L.8
Lenrow, D.A.9
Holmes, J.H.10
Kapoor, S.C.11
Atkinson, L.E.12
Strom, B.L.13
-
28
-
-
2442543161
-
Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men
-
Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Berman N, Hull L, Swerdloff RS. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 2004;89:2085-2098.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 2085-2098
-
-
Wang, C.1
Cunningham, G.2
Dobs, A.3
Iranmanesh, A.4
Matsumoto, A.M.5
Snyder, P.J.6
Weber, T.7
Berman, N.8
Hull, L.9
Swerdloff, R.S.10
-
29
-
-
33947169475
-
Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only
-
Yassin AA, Saad F. Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only. J Sex Med 2007;4:497-501.
-
(2007)
J Sex Med
, vol.4
, pp. 497-501
-
-
Yassin, A.A.1
Saad, F.2
-
30
-
-
10244234214
-
Testosterone replacement therapy improves mood in hypogonadal men-a clinical research center study
-
Wang C, Alexander G, Berman N, Salehian B, Davidson T, McDonald V, Steiner B, Hull L, Callegari C, Swerdloff RS. Testosterone replacement therapy improves mood in hypogonadal men-a clinical research center study. J Clin Endocrinol Metab 1996;81:3578-3583.
-
(1996)
J Clin Endocrinol Metab
, vol.81
, pp. 3578-3583
-
-
Wang, C.1
Alexander, G.2
Berman, N.3
Salehian, B.4
Davidson, T.5
McDonald, V.6
Steiner, B.7
Hull, L.8
Callegari, C.9
Swerdloff, R.S.10
-
31
-
-
33845762711
-
Testosterone and men's quality of life
-
Moncada I. Testosterone and men's quality of life. Aging Male 2006;9:189-193.
-
(2006)
Aging Male
, vol.9
, pp. 189-193
-
-
Moncada, I.1
-
32
-
-
69949178483
-
Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone
-
Heufelder AE, Saad F, Bunck MC, Gooren L. Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. J Androl 2009;30:726-733.
-
(2009)
J Androl
, vol.30
, pp. 726-733
-
-
Heufelder, A.E.1
Saad, F.2
Bunck, M.C.3
Gooren, L.4
-
33
-
-
77949503625
-
Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate
-
Haider A, Gooren LJ, Padungtod P, Saad F. Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate. Exp Clin Endocrinol Diabetes 2010;118:167-171.
-
(2010)
Exp Clin Endocrinol Diabetes
, vol.118
, pp. 167-171
-
-
Haider, A.1
Gooren, L.J.2
Padungtod, P.3
Saad, F.4
-
34
-
-
84882281522
-
Trends in androgen prescribing in the United States, 2001 to 2011
-
Baillargeon J, Urban RJ, Ottenbacher KJ, Pierson KS, Goodwin JS. Trends in androgen prescribing in the United States, 2001 to 2011. JAMA Intern Med 2013;173:1465-1466.
-
(2013)
JAMA Intern Med
, vol.173
, pp. 1465-1466
-
-
Baillargeon, J.1
Urban, R.J.2
Ottenbacher, K.J.3
Pierson, K.S.4
Goodwin, J.S.5
-
35
-
-
84859509755
-
Testosterone treatment in the aging male: Myth or reality?
-
Nigro N, Christ-Crain M. Testosterone treatment in the aging male: Myth or reality? Swiss Med Wkly 2012;142:w13539.
-
(2012)
Swiss Med Wkly
, vol.142
, pp. w13539
-
-
Nigro, N.1
Christ-Crain, M.2
-
36
-
-
77949426910
-
The benefits and risks of testosterone replacement therapy: A review
-
Bassil N, Alkaade S, Morley JE. The benefits and risks of testosterone replacement therapy: A review. Ther Clin Risk Manag 2009;5:427-448.
-
(2009)
Ther Clin Risk Manag
, vol.5
, pp. 427-448
-
-
Bassil, N.1
Alkaade, S.2
Morley, J.E.3
-
37
-
-
17744374771
-
Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men
-
Swerdloff RS, Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Longstreth J, Berman N. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab 2000;85:4500-4510.
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 4500-4510
-
-
Swerdloff, R.S.1
Wang, C.2
Cunningham, G.3
Dobs, A.4
Iranmanesh, A.5
Matsumoto, A.M.6
Snyder, P.J.7
Weber, T.8
Longstreth, J.9
Berman, N.10
-
38
-
-
58449105426
-
Hyperandrogenism after transfer of topical testosterone gel: Case report and review of published and unpublished studies
-
de Ronde W. Hyperandrogenism after transfer of topical testosterone gel: Case report and review of published and unpublished studies. Hum Reprod 2009;24:425-428.
-
(2009)
Hum Reprod
, vol.24
, pp. 425-428
-
-
de Ronde, W.1
-
40
-
-
0037236825
-
A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function
-
McNicholas TA, Dean JD, Mulder H, Carnegie C, Jones NA. A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function. BJU Int 2003;91:69-74.
-
(2003)
BJU Int
, vol.91
, pp. 69-74
-
-
McNicholas, T.A.1
Dean, J.D.2
Mulder, H.3
Carnegie, C.4
Jones, N.A.5
-
41
-
-
10344243498
-
Prevalence and incidence of androgen deficiency in middle-aged and older men: Estimates from the Massachusetts Male Aging Study
-
Araujo AB, O'Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM, McKinlay JB. Prevalence and incidence of androgen deficiency in middle-aged and older men: Estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2004;89:5920-5926.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 5920-5926
-
-
Araujo, A.B.1
O'Donnell, A.B.2
Brambilla, D.J.3
Simpson, W.B.4
Longcope, C.5
Matsumoto, A.M.6
McKinlay, J.B.7
-
42
-
-
80054797449
-
Hypogonadism as a risk factor for cardiovascular mortality in men: A meta-analytic study
-
Corona G, Rastrelli G, Monami M, Guay A, Buvat J, Sforza A, Forti G, Mannucci E, Maggi M. Hypogonadism as a risk factor for cardiovascular mortality in men: A meta-analytic study. Eur J Endocrinol 2011;165:687-701.
-
(2011)
Eur J Endocrinol
, vol.165
, pp. 687-701
-
-
Corona, G.1
Rastrelli, G.2
Monami, M.3
Guay, A.4
Buvat, J.5
Sforza, A.6
Forti, G.7
Mannucci, E.8
Maggi, M.9
-
43
-
-
80054827649
-
Type 2 diabetes mellitus and testosterone: A meta-analysis study
-
Corona G, Monami M, Rastrelli G, Aversa A, Sforza A, Lenzi A, Forti G, Mannucci E, Maggi M. Type 2 diabetes mellitus and testosterone: A meta-analysis study. Int J Androl 2011;34:528-540.
-
(2011)
Int J Androl
, vol.34
, pp. 528-540
-
-
Corona, G.1
Monami, M.2
Rastrelli, G.3
Aversa, A.4
Sforza, A.5
Lenzi, A.6
Forti, G.7
Mannucci, E.8
Maggi, M.9
-
45
-
-
80054827093
-
Onset of effects of testosterone treatment and time span until maximum effects are achieved
-
Saad F, Aversa A, Isidori AM, Zafalon L, Zitzmann M, Gooren L. Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol 2011;165:675-685.
-
(2011)
Eur J Endocrinol
, vol.165
, pp. 675-685
-
-
Saad, F.1
Aversa, A.2
Isidori, A.M.3
Zafalon, L.4
Zitzmann, M.5
Gooren, L.6
-
47
-
-
0035160713
-
Treatment options for a patient experiencing pruritic rash associated with transdermal testosterone: A review of the literature
-
McGriff NJ, Csako G, Kabbani M, Diep L, Chrousos GP, Pucino F. Treatment options for a patient experiencing pruritic rash associated with transdermal testosterone: A review of the literature. Pharmacotherapy 2001;21:1425-1435.
-
(2001)
Pharmacotherapy
, vol.21
, pp. 1425-1435
-
-
McGriff, N.J.1
Csako, G.2
Kabbani, M.3
Diep, L.4
Chrousos, G.P.5
Pucino, F.6
-
49
-
-
84876969942
-
Medication adherence and treatment patterns for hypogonadal patients treated with topical testosterone therapy: A retrospective medical claims analysis
-
Schoenfeld MJ, Shortridge E, Cui Z, Muram D. Medication adherence and treatment patterns for hypogonadal patients treated with topical testosterone therapy: A retrospective medical claims analysis. J Sex Med 2013;10:1401-1409.
-
(2013)
J Sex Med
, vol.10
, pp. 1401-1409
-
-
Schoenfeld, M.J.1
Shortridge, E.2
Cui, Z.3
Muram, D.4
-
50
-
-
63149194127
-
Testosterone gel monotherapy improves sexual function of hypogonadal men mainly through restoring erection: Evaluation by IIEF score
-
Chiang HS, Cho SL, Lin YC, Hwang TI. Testosterone gel monotherapy improves sexual function of hypogonadal men mainly through restoring erection: Evaluation by IIEF score. Urology 2009;73:762-766.
-
(2009)
Urology
, vol.73
, pp. 762-766
-
-
Chiang, H.S.1
Cho, S.L.2
Lin, Y.C.3
Hwang, T.I.4
-
51
-
-
68049144803
-
A randomized, double-blind, placebo-controlled study of testosterone treatment in hypogonadal older men with subthreshold depression (dysthymia or minor depression)
-
Shores MM, Kivlahan DR, Sadak TI, Li EJ, Matsumoto AM. A randomized, double-blind, placebo-controlled study of testosterone treatment in hypogonadal older men with subthreshold depression (dysthymia or minor depression). J Clin Psychiatry 2009;70:1009-1016.
-
(2009)
J Clin Psychiatry
, vol.70
, pp. 1009-1016
-
-
Shores, M.M.1
Kivlahan, D.R.2
Sadak, T.I.3
Li, E.J.4
Matsumoto, A.M.5
-
52
-
-
84878704250
-
Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes
-
Hackett G, Cole N, Bhartia M, Kennedy D, Raju J, Wilkinson P. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes. J Sex Med 2013;10:1612-1627.
-
(2013)
J Sex Med
, vol.10
, pp. 1612-1627
-
-
Hackett, G.1
Cole, N.2
Bhartia, M.3
Kennedy, D.4
Raju, J.5
Wilkinson, P.6
-
53
-
-
84890063675
-
Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss
-
Yassin AA, Doros G. Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss. Clin Obes 2013;3:73-83.
-
(2013)
Clin Obes
, vol.3
, pp. 73-83
-
-
Yassin, A.A.1
Doros, G.2
-
54
-
-
84885371224
-
Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss
-
Silver Spring
-
Saad F, Haider A, Doros G, Traish A. Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss. Obesity (Silver Spring) 2013;21:1975-1981.
-
(2013)
Obesity
, vol.21
, pp. 1975-1981
-
-
Saad, F.1
Haider, A.2
Doros, G.3
Traish, A.4
-
55
-
-
51649103492
-
Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1,000mg IM-Nebido)
-
Moisey R, Swinburne J, Orme S. Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1, 000mg IM-Nebido). Clin Endocrinol (Oxf) 2008;69:642-647.
-
(2008)
Clin Endocrinol (Oxf)
, vol.69
, pp. 642-647
-
-
Moisey, R.1
Swinburne, J.2
Orme, S.3
|